TOI, Yukihiro et al. Association of low body surface area with dose reduction and/or discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: a pilot study: BSA and nintedanib reduction/discontinuation. Sarcoidosis, Vasculitis and Diffuse Lung Diseases, Fidenza, Italy, v. 36, n. 1, p. 74–78, 2019. DOI: 10.36141/svdld.v36i1.7383. Disponível em: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/7383.. Acesso em: 26 nov. 2024.